Clinical trials
Not yet recruiting Phase 2 Lymphoma, Large B-Cell, Diffuse trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 6 |
| 2025 | 3 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ruijin Hospital | 5 |
| The First Affiliated Hospital of Soochow University | 2 |
| The First Affiliated Hospital with Nanjing Medical University | 2 |
| AbelZeta Inc. | 1 |
| Brown University | 1 |
| Carrie Ho, MD | 1 |
| Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 1 |
| Innovent Biologics (Suzhou) Co. Ltd. | 1 |
| Joshua Brody | 1 |
| Kure Cells, INC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Large B-Cell, Diffuse | 22 |
| Lymphoma, B-Cell | 3 |
| Recurrence | 3 |
| Dendritic Cell Sarcoma, Interdigitating | 2 |
| Lymphoma | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Lymphoma, B-Cell, Marginal Zone | 1 |
| Lymphoma, Follicular | 1 |
| Lymphoma, Mantle-Cell | 1 |
| Neoplasm, Residual | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.